2007 Another Record Year in Terms of Sales and Earnings for Ge...(liquid formulations and solid dosages (f...)

Date:2/4/2008

liquid formulations and solid dosages (for example eye drops and tablets), which ideally complement - and can be combined with - Gerresheimer's product range. The Group's existing product portfolio in the field of plastic packaging, which has so far been marketed primarily in Europe, will as a result increasingly find its way into the South American pharmaceutical markets.

Allplas currently achieves annual sales equivalent to around EUR16m. The EBITDA margin is 16%, which will be continuously improved in the years ahead. Integration in the Gerresheimer Group is to be completed by mid-2008. Like EDP, Allplas will become part of Gerresheimer Plastic Packaging, which specialises in pharmaceutical primary packaging and application systems under leading trade­marks such as Duma(R), Dudek(TM) and EDP(TM). Together with the two acquisitions, Gerresheimer's plastic operations achieve a total annual sales volume of around EUR350m, of which around EUR100m is attributable to the plastic packaging segment.

About Gerresheimer

Including the two acquisitions, Gerresheimer employs more than 10,800 people in forty locations in Europe, America and Asia. In the financial year 2007, worldwide sales totalled EUR957.7m. The product portfolio ranges from pharmaceutical vials made of glass and plastic to complex drug-delivery systems for the pharma and life-science industry. These include sterile syringes, inhalers and other system solutions for secure dosage and application of medications. The Group enjoys a leading position in a market which is characterised by high technical and regulatory barriers. Gerresheimer's products are subject to extremely rigorous quality requirements stipulated by the international pharmaceutical supervision authorities.

Press Dates

Annual Press Conference February 26 2008

Annual General Meeting April 17, 2008

Contact:

Burkhard Lingenberg

Director Corporate PR & Marketing

<
'/>"/>

SOURCE Gerresheimer AG Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
2. Signalife Receives Another $3.3 Million Sales Orders
3. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
4. CryoLife Announces Record Preservation Services and Product Revenues for 2007
5. Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
6. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
7. Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order
8. Protalix BioTherapeutics Sets Record Date for Annual Meeting of Shareholders
9. Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device
10. The Female Health Company Reports Record Profit for Both Fourth Quarter and Fiscal Year 2007
11. KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis